The Dystonia Discomfort Scale (DDS): A novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia

European Journal of Neurology

Volumn 21, Issue 3, 2014, Pages 459-462

  Dressler, D ^a   Kupsch, A ^b,c   Seitzinger, A ^d   Paus, S ^e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d MERZ PHARMACEUTICALS GMBH   (Germany)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

Botulinum toxin; Cervical dystonia; Dystonia Discomfort Scale; Temporal profile; Therapeutic use

Indexed keywords

BOTULINUM TOXIN; CERVICAL DYSTONIA; DYSTONIA DISCOMFORT SCALE; TEMPORAL PROFILE; THERAPEUTIC USE;

ADULT; AGED; BOTULINUM TOXINS, TYPE A; DRUG MONITORING; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SELF-ASSESSMENT; SEVERITY OF ILLNESS INDEX; TORTICOLLIS; TREATMENT OUTCOME;

EID: 84893842094     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12330     Document Type: Article

References (8)

1. Dressler D. Five-year experience with incobotulinum-toxinA (Xeomin®): the first botulinum toxin drug free of complexing proteins. Eur J Neurol 2012; 19: 385-389.
2. Simpson DM, Blitzer A, Brashear A, et al. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70: 1699-1706.
3. Truong D, Dressler D, Hallett M. Manual of Botulinum Toxin Therapy, 1 edn. Cambridge, UK: Cambridge University Press, 2009.
4. Dressler D, Adib SF. Botulinum toxin: mechanisms of action. Eur Neurol 2005; 53: 3-9.
5. Consky ES, Lang AE. Clinical assessments of patients with cervical dystonia. In: Jankovic J, Hallett M, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker Inc., 1994: 211-237.
6. Jost WH, Hefter H, Stenner A, Reichel G. Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy. J Neural Transm 2013; 120: 487-496.
7. Interdisziplinärer Arbeitskreis Bewegungsstörungen. http://dds.iabnetz.de (accessed 09/07/2013).
8. Dressler D, Paus S, Seitzinger A, Gebhardt B, Kupsch A. Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia. J Neurol Neurosurg Psychiatry 2013; 84: 1014-1019.